COVID-19 has disrupted traditional healthcare and accelerated digital healthcare options. Our latest MedData Point Infographic research found that 89% of Healthcare Professionals (HCPs) are currently using telehealth technologies to provide patient care. Right now, 40% of Specialist and 35% of Primary Care patient visits are occurring remotely via telehealth, and physician use of telehealth services is expected to remain at current levels post-COVID-19*. What’s more, face-to-face meetings between pharmaceutical reps and HCPs are down 92% with no real signs of rebounding*, meaning your HCP digital targeting strategy is more important than ever.

MedData Group, an IQVIA business, has developed a unique set of segmentable Telehealth Audiences, created from 375K+ HCPs within Healthcare Organizations (HCOs) billing for Telehealth consultations, visits, and remote monitoring across a myriad of professions and specialties.

Each segment is created by leveraging the IQVIA OneKey reference data set, the gold standard across the professional health ecosystem providing compliance grade data on over 10M HCPs. The incorporation of OneKey ensures that you are targeting the most accurate and complete universe of HCPs actively diagnosing, treating, and prescribing medications through the use of telehealth-related technologies.

Engage your Telehealth audiences through the full omnichannel digital advertising spectrum, including:

  • Email
  • Programmatic
  • Social Media
  • Advanced TV

*IQVIA internal research. As the Human Data Science company, IQVIA is ready to help reduce the impact of COVID-19 today, and provide hope for the future.

LEARN MORE ABOUT OUR TELEHEALTH HCP SEGMENTS:

[hubspotform portal_id=”3787061″ form_id=”f9eae095-8725-4d5c-a363-3dde5c2969ec” css=””]